Cargando…
Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium
BACKGROUND: Robust and reliable in vitro and in vivo models of primary cells are necessary to study the pathomechanisms of Myelodysplastic Neoplasms (MDS) and identify novel therapeutic strategies. MDS-derived hematopoietic stem and progenitor cells (HSPCs) are reliant on the support of bone marrow...
Autores principales: | Altrock, Eva, Sens-Albert, Carla, Hofmann, Franziska, Riabov, Vladimir, Schmitt, Nanni, Xu, Qingyu, Jann, Johann-Christoph, Rapp, Felicitas, Steiner, Laurenz, Streuer, Alexander, Nowak, Verena, Obländer, Julia, Weimer, Nadine, Palme, Iris, Göl, Melda, Darwich, Ali, Wuchter, Patrick, Metzgeroth, Georgia, Jawhar, Mohamad, Hofmann, Wolf-Karsten, Nowak, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249283/ https://www.ncbi.nlm.nih.gov/pubmed/37287056 http://dx.doi.org/10.1186/s13287-023-03386-5 |
Ejemplares similares
-
In Silico Pan-Cancer Analysis Reveals Prognostic Role of the Erythroferrone (ERFE) Gene in Human Malignancies
por: Xu, Qingyu, et al.
Publicado: (2023) -
Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo
por: Jann, Johann-Christoph, et al.
Publicado: (2021) -
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
por: Flach, Johanna, et al.
Publicado: (2020) -
Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies
por: Xu, Qingyu, et al.
Publicado: (2023) -
Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes
por: Schmitt, Nanni, et al.
Publicado: (2021)